Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

Clinical trial NCT05537948 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05537948
Sponsor: National Medical Research Center for Therapy and Preventive Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Dyslipidemias Hyperlipidemias Liver Transplant Disorder Immunosuppression Hydroxymethylglutaryl-CoA Reductase Inhibitors Statins

Start date: 2021-10-01
Primary completion: 2024-01-31
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.